image
Research Frontiers Incorporated REFR
Technology - Hardware, Equipment & Parts - NASDAQ - US
Watchlist
$ 1.02
-4.67 %
$ 34.3 M
Market Cap
-25.5
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one REFR stock under the worst case scenario is HIDDEN Compared to the current market price of 1.02 USD, Research Frontiers Incorporated is HIDDEN

REFR Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one REFR stock under the base case scenario is HIDDEN Compared to the current market price of 1.02 USD, Research Frontiers Incorporated is HIDDEN

REFR Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one REFR stock under the best case scenario is HIDDEN Compared to the current market price of 1.02 USD, Research Frontiers Incorporated is HIDDEN

REFR Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart REFR

image
1M -19%
6M -97%
1Y -50%
3Y -95%
5Y -143%
All
$2.4$2.4$2.2$2.2$2.0$2.0$1.8$1.8$1.6$1.6$1.4$1.4$1.2$1.2$1.0$1.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
1.34 M REVENUE
46.83%
Growth Rates
1Year 46.83%
3Years 1.88%
5Years -3.11%
7Years -1.73%
10Years -1.78%
-1.44 M OPERATING INCOME
29.09%
Growth Rates
1Year 29.09%
3Years 7.79%
5Years 14.74%
7Years 7.12%
10Years 10.66%
-1.31 M NET INCOME
31.28%
Growth Rates
1Year 31.28%
3Years 10.78%
5Years 19.21%
7Years 8.35%
10Years 11.43%
-789 K OPERATING CASH FLOW
65.63%
Growth Rates
1Year 65.63%
3Years 24.10%
5Years 17.65%
7Years 8.51%
10Years 13.40%
-1.62 K INVESTING CASH FLOW
-2.92%
Growth Rates
1Year -2.92%
3Years 91.65%
5Years 52.24%
7Years -0.02%
10Years -0.01%
309 K FINANCING CASH FLOW
-36.29%
Growth Rates
1Year -36.29%
3Years 52.95%
5Years -44.33%
7Years 0.00%
10Years -21.74%
178 K REVENUE
-49.73%
Growth Rates
1Year 46.83%
3Years 1.88%
5Years -3.11%
7Years -1.73%
10Years -1.78%
-624 K OPERATING INCOME
-169.43%
Growth Rates
1Year 29.09%
3Years 7.79%
5Years 14.74%
7Years 7.12%
10Years 10.66%
-608 K NET INCOME
-264.44%
Growth Rates
1Year 31.28%
3Years 10.78%
5Years 19.21%
7Years 8.35%
10Years 11.43%
47.1 K OPERATING CASH FLOW
118.25%
Growth Rates
1Year 65.63%
3Years 24.10%
5Years 17.65%
7Years 8.51%
10Years 13.40%
-881 INVESTING CASH FLOW
-49.83%
Growth Rates
1Year -2.92%
3Years 91.65%
5Years 52.24%
7Years -0.02%
10Years -0.01%
300 K FINANCING CASH FLOW
0.00%
Growth Rates
1Year -36.29%
3Years 52.95%
5Years -44.33%
7Years 0.00%
10Years -21.74%
Balance Sheet Research Frontiers Incorporated
image
Current Assets 2.75 M
Cash & Short-Term Investments 1.99 M
Receivables 658 K
Other Current Assets 93.5 K
Non-Current Assets 1.29 M
Long-Term Investments 0
PP&E 1.24 M
Other Non-Current Assets 56.1 K
49.37 %16.29 %30.64 %Total Assets$4.0m
Current Liabilities 269 K
Accounts Payable 85.8 K
Short-Term Debt 130 K
Other Current Liabilities 53.3 K
Non-Current Liabilities 1.17 M
Long-Term Debt 1.17 M
Other Non-Current Liabilities 0
5.98 %9.05 %3.72 %81.26 %Total Liabilities$1.4m
EFFICIENCY
Earnings Waterfall Research Frontiers Incorporated
image
Revenue 1.34 M
Cost Of Revenue 0
Gross Profit 1.34 M
Operating Expenses 2.78 M
Operating Income -1.44 M
Other Expenses -130 K
Net Income -1.31 M
2m2m1m1m500k500k00(500k)(500k)(1m)(1m)(1m)(1m)1m01m(3m)(1m)130k(1m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
Averages
1Year 100.00%
3Years 2.71%
5Years -65.36%
7Years -70.55%
10Years -96.79%
-107.96% OPERATING MARGIN
-107.96%
Averages
1Year -107.96%
3Years -272.64%
5Years -254.92%
7Years -234.52%
10Years -236.26%
-98.19% NET MARGIN
-98.19%
Averages
1Year -98.19%
3Years -270.27%
5Years -242.32%
7Years -239.68%
10Years -239.38%
-50.35% ROE
-50.35%
Averages
1Year -50.35%
3Years -53.72%
5Years -49.93%
7Years -57.09%
10Years -62.73%
-32.46% ROA
-32.46%
Averages
1Year -32.46%
3Years -44.20%
5Years -41.46%
7Years -46.80%
10Years -53.66%
-36.97% ROIC
-36.97%
Averages
1Year -36.97%
3Years -46.53%
5Years -43.27%
7Years -46.22%
10Years -55.11%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Research Frontiers Incorporated
image
00(500k)(500k)(1m)(1m)(1m)(1m)(2m)(2m)(2m)(2m)(3m)(3m)(3m)(3m)(4m)(4m)(4m)(4m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -1.31 M
Depreciation & Amortization 264 K
Capital Expenditures -1.62 K
Stock-Based Compensation 89.3 K
Change in Working Capital 145 K
Others 95.6 K
Free Cash Flow -790 K
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Research Frontiers Incorporated
image
REFR has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Research Frontiers Incorporated
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
11.4 K USD 2
9-12 MONTHS
7. News
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025 - The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater - - The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα expression of 25% or greater - globenewswire.com - 1 month ago
Research Frontiers Incorporated (REFR) Q4 2024 Earnings Call Transcript Research Frontiers Incorporated (NASDAQ:REFR ) Q4 2024 Earnings Conference Call March 6, 2025 4:30 PM ET Company Participants Joe Harary - President & Chief Executive Officer Conference Call Participants Alan Yakuboff - Kingsview Partners Operator Good afternoon, and welcome to Research Frontiers Investor Conference Call to discuss the Fourth Quarter and Full Year 2024 Results of Operations and Recent Developments. The company will be answering many of the questions that were emailed to it, prior to this conference call either in their presentation or as part of the Q&A session at the end. seekingalpha.com - 1 month ago
Research Frontiers Reports 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today WOODBURY, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq:  REFR ) announced its financial results for its fourth quarter and full-year 2024. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments. globenewswire.com - 1 month ago
RESEARCH FRONTIERS TO HOST YEAR-END 2024 CONFERENCE CALL WOODBURY, NY, March 03, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its fourth quarter and full-year 2024 financial results on Thursday, March 6, 2025. Research Frontiers will host a conference call at 4:30 p.m. globenewswire.com - 1 month ago
Research Frontiers Incorporated (REFR) Q3 2024 Earnings Call Transcript Research Frontiers Incorporated (NASDAQ:REFR ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Joe Harary - President and CEO Operator Good afternoon, ladies and gentlemen. Welcome to the Research Frontiers Investor Conference Call to discuss the Third Quarter of 2024 Results of Operations and Recent Developments [Operator Instructions]. seekingalpha.com - 5 months ago
RESEARCH FRONTIERS TO HOST THIRD QUARTER 2024 CONFERENCE CALL WOODBURY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq:  REFR ) announced today that it will release its third quarter 2024 financial results on Thursday, November 7, 2024. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, November 7, 2024 to discuss its third quarter 2024 financial and operating results, as well as recent developments. globenewswire.com - 5 months ago
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that REFRαME-P1, the registration-directed study of luveltamab tazevibulin (luvelta) for pediatric patients with CBFA2T3::GLIS2 (CBF/GLIS; RAM phenotype) acute myeloid leukemia (AML), has been initiated and is open for enrollment. globenewswire.com - 5 months ago
Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer SOUTH SAN FRANCISCO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that REFRαME-L1, the global Phase 2 study of luveltamab tazevibulin (luvelta) for patients with non-small cell lung cancer (NSCLC) whose tumor expresses Folate Receptor-α (FRα), has been initiated and is open for enrollment. Initial data from this study is expected in the first half of 2025. globenewswire.com - 7 months ago
Research Frontiers, Inc. (REFR) Q2 2024 Earnings Call Transcript Research Frontiers, Inc. (NASDAQ:REFR ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Joe Harary - President & CEO Conference Call Participants Neal Goldman - Goldman Capital Management Michael Kay - Kay Associates Leonard Lietzow - Private Investor Jeff Harvey - Private Investor Allen Ginsberg - Private Investor Operator Good afternoon ladies and gentlemen. Welcome to the Research Frontiers Investor Conference Call to discuss the Second Quarter of 2024 results of operations and recent developments. seekingalpha.com - 8 months ago
Research Frontiers Reports Second Quarter 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today WOODBURY, N.Y., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR ) announced its financial results for its second quarter of 2024. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments. globenewswire.com - 8 months ago
RESEARCH FRONTIERS TO HOST SECOND QUARTER 2024 CONFERENCE CALL WOODBURY, NY, July 29, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq:  REFR ) announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, August 1, 2024 to discuss its second quarter 2024 financial and operating results, as well as recent developments. globenewswire.com - 8 months ago
Research Frontiers and AIT Group Unveil Revolutionary Retrofittable SPD-SmartGlass Window At AIA Conference on Architecture & Design in Washington DC Washington DC, June 06, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR), the inventor and licensor of patented SPD-Smart film light-control technology, and AIT Group, a fully-integrated premier manufacturer of advanced functional glass solutions, and licensee of Research Frontiers' technology, announced today the introduction of a breakthrough retrofittable SPD-SmartGlass window. Introducing the Thermolite RetroWAL SPD system! This innovative product will be unveiled for the first time at the AIA Expo 2024 in Washington, DC, from June 6-7, 2024, at Booth 720. globenewswire.com - 10 months ago
8. Profile Summary

Research Frontiers Incorporated REFR

image
COUNTRY US
INDUSTRY Hardware, Equipment & Parts
MARKET CAP $ 34.3 M
Dividend Yield 0.00%
Description Research Frontiers Incorporated develops and markets technology and devices to control the flow of light worldwide. The company develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, and electronics to power end-products incorporating the film, as well as lamination services for and the end-products, such as windows, skylights, and sunroofs. Its SPD-Smart light-control technology is used in various product applications, including windows, sunshades, skylights, and interior partitions for homes and buildings; automotive windows, sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels, and navigation systems; aircraft windows; museum display panels, and eyewear products; and flat panel displays for electronic products. The company serves architectural, automotive, marine, and aerospace and appliance applications. Research Frontiers Incorporated was incorporated in 1965 and is headquartered in Woodbury, New York.
Contact 240 Crossways Park Drive, Woodbury, NY, 11797-2033 https://www.smartglass.com
IPO Date July 8, 1986
Employees 6
Officers Mr. Joseph M. Harary J.D. Chief Executive Officer, President, General Counsel, Corporate Secretary & Director